Observing the Role of Inflammation in Peripheral Artery Disease and Its Impact on Heart and Mobility Health: PANACEA-O.
A legfontosabb adatok
- Ki végzi
- Cardiology Research UBC
- Hol
- Kanada1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 50 fő, tervezett
- Kezdés
- 2025. szept. 25.
- Tervezett befejezés
- 2026. júl.
- A vizsgálat típusa
- Megfigyeléses
- A regiszteradat frissítve
- 2026. március 30.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults in Canada with peripheral artery disease (narrowed leg arteries) who get leg pain when walking. People are seen in heart clinics and still live in the community. This is an observational study.
- Életkor
- 19 years or older
- Nem
- All sexes
- A betegség stádiuma
- Stable leg pain when walking (Fontaine stage IIa) for at least 90 days. You can walk more than 200 m/656 feet/2 blocks without stopping.
- Korábbi kezelés
- No immunomodulating agent (a drug that changes the immune system) in the 90 days before screening. No artery-opening procedure for PAD in the 180 days before screening.
- Biomarker vagy leletérték
- Ankle-brachial-index (ABI) of 0.90 or below, or at least 50% narrowing of a leg artery (not the carotid) on a scan, or a past procedure to reopen leg arteries.
A részvétel fő kizáró okai
- Walking limited by conditions other than PAD
- Planned leg bone surgery, other major surgery or artery-opening procedure
- Heart attack, stroke, mini-stroke or hospital stay for unstable chest pain in the past 180 days
- Heart failure NYHA class III-IV
- Signs of critical limb ischemia, such as gangrene, pain at rest or wounds
A regiszter feltételei, szó szerint
Mind a 11 feltétel megnézéseKevesebb
Ki vehet részt
- Age >/= 19 years of age
- Ability to provide informed consent before any trial-related activities
- Symptomatic PAD with intermittent claudication corresponding to Fontaine stage IIa meeting all of the following:; Stable symptoms of PAD with intermittent claudication in Fontaine stage IIa (able to walk without stopping more than 200 m/656 feet/2 blocks) for at least 90 days prior to the day of screening based on patient interview; Ankle-brachial-index (ABI) equal to or below 0.90 (the leg with lowest index is chosen in case of bilateral disease) or ≥ 50% stenosis in peripheral artery (excluding carotid) documented by X-ray angiography, MR angiography, CT angiography or Doppler ultrasound, or a history of lower extremity revascularization
Ki nem vehet részt
- Current or previous treatment with any immunomodulating agent within 90 days prior to the day of screening
- Planned orthopaedic surgery in the legs, or other major surgery known on the day of screening (surgery affecting walking ability)
- Vascular revascularisation procedure for PAD of any kind 180 days prior to the day of screening
- Myocardial infarction, stroke, hospitalisation for unstable angina pectoris or transient ischemic attack within 180 days prior to the day of screening
- Walking ability limited by conditions other than PAD
- Heart failure presently classified as being in New York Heart Association (NYHA) class III-IV
- Planned arterial revascularisation known on the day of screening
- Signs/symptoms of critical limb ischemia (leg gangrene, rest pain, ischemic wounds, etc)
Ez a vizsgálat jelenleg itt érhető el: Kanada.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
This registry aims to collect detailed information about people in Canada who have Peripheral Artery Disease (PAD) and are receiving care in heart clinics while still able to walk and live in the community. Researchers want to better understand what these patients are like at the start of their care and looking at their general health, levels of inflammation in their bodies, and how well they can move and function in daily life.
A teljes eredeti leírásKevesebb
The results of this study will help healthcare providers better understand what PAD looks like in today's Canadian heart clinics. It will also help guide future research studies that focus on inflammation and PAD. The researchers believe that PAD patients can be routinely recruited from these clinics, and that most of these patients will have high levels of inflammation (shown by high blood CRP levels) and poor physical ability when they first join. The findings will show that there is a strong need to regularly check for PAD in heart clinics so that patients can be identified early and offered new treatments in the future and especially treatments that may help reduce inflammation.
A vizsgálat csoportja
- PAD
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Protocol Title Peripheral Arterial Disease and InflammatioN Study Assessing the Cardiovascular and Functional Effects - Observational Study: PANACEA-O
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. március 30.